Downloads

1. Closing The CAR-T Access Gap With Hospital-Based Manufacturing 10/30/2026

   Improvements in closed-loop processing and lower material costs could bring distributed manufacturing within reach. Hospitals still need to stand up production suites.

2. How To Stand Up A Hospital-Based CAR-T Manufacturing Network 10/30/2026

   Estimates show that a small hospital-based, modular GMP facility can deliver more than 250 products per year with more flexibility than fully automated, integrated equipment.

3. The Human Side Of Drug Development 10/29/2026

   Behind every therapeutic breakthrough are experts navigating complex challenges. Hear the decisions, lessons, and experiences shaping modern medicine in this podcast episode.

4. BPAL Case Study: Solving Downstream Purification Challenges For Partners 10/29/2026

   An aggregation-prone monoclonal antibody exposed the limits of a standard Protein A platform. A staged screening and column study tested whether tailored capture and polishing could improve recovery and purity.

5. Rethinking Starting Material: Whole Blood For Autologous T-Cell Manufacture 10/28/2026

   Matching starting material to process requirements in autologous T-cell manufacturing, and where whole blood may stand in for leukapheresis without compromising what the process needs.

6. September 2026 — CDMO Opportunities And Threats Report 10/28/2026

   Each month, Outsourced Pharma works in conjunction with PharmSource, part of GlobalData, to present its “Contract Manufacturing: Opportunities and Threats (CMOT) Report” to our readers. The report identifies CDMOs that might be impacted by key events affecting their clients, including company acquisitions, product acquisitions and licenses, product approvals, late clinical product terminations, and FDA rejections.

7. 3-In-1 Protocol For Rapid CAR-T Cell Manufacturing 10/28/2026

   Closing the process and merging three steps into one perfusion run brings CAR-T manufacturing down to roughly a week, with fewer open events and lower batch failure risk.

8. Quantum Flex Cell Expansion System: Inspired By Human Biology, Designed To Scale 10/28/2026

   Cell expansion built around low seeding requirements and high yields in 1 L or less. A bioreactor design drawn from human biology aims to simplify scale-up.

9. Unlocking Hidden Efficiencies In Cell And Gene Therapy Manufacturing 10/28/2026

   Identify hidden bottlenecks, cut batch variability, reduce costs, and protect quality. Learn strategies to streamline GMP transitions and speed commercialization.

10. Guaranteed Tech Transfer And Process Development – Or Your Money Back 10/28/2026

    De-risk biotech development with guaranteed tech transfer and process support. Safeguard your investment from cell line development through protein optimization.